【査読付き英文論文】

*1. Piao L, Fujioka K, Nakakido M, Hamamoto R: Regulation of poly(ADP-Ribose) polymerase 1 functions by post-translational modifications. Frontiers in Bioscience, 23, 13-26 (2018) [pubmed]

*2. Kunizaki M, Tominaga T, Wakata K, Miyazaki T, Matsumoto K, Sumida Y, Hidaka S, Yamasaki T, Yasutake T, Sawai T, Hamamoto R, Nanashima A, Nagayasu T: Clinical significance of the C-reactive protein-to-albumin ratio for the prognosis of patients with esophageal squamous cell carcinoma. Molecular and Clinical Oncology, 8, 370-374 (2018) [pubmed]

*3. Kunizaki M, Hamasaki K, Wakata K, Tobinaga S, Sumida Y, Hidaka S, Yasutake T, Miyazaki T, Matsumoto K, Yamasaki T, Sawai T, Hamamoto R, Nanashima A, Nagayasu T: Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Esophageal Squamous. Anticancer Research, 38, 1807-1813 (2018) [pubmed]

*4. Toyokawa G, Takada K, Tagawa T, Kinoshita F, Kozuma Y, Matsubara T, Haratake N, Takamori S, Akamine T, Hirai F, Yamada Y, Hamamoto R, Oda Y, Maehara Y: Prevalence of Enhancer of Zeste Homolog 2 in Patients with Resected Small Cell Lung Cancer. Anticancer Research, 38, 3707-3711 (2018) [pubmed]

*5. Shigekawa Y, Hayami S, Ueno M, Miyamoto A, Suzaki N, Kawai M, Hirono S, Okada KI, Hamamoto R, Yamaue H:　Overexpression of KDM5B/JARID1B is associated with poor prognosis in hepatocellular carcinoma. Oncotarget, 9, 34320-34335 (2018) [pubmed]

*6. Lee CH, Yu JR, Kumar S, Jin Y, LeRoy G, Bhanu N, Kaneko S, Garcia BA, Hamilton AD, Reinberg D: Allosteric Activation Dictates PRC2 Activity Independent of Its Recruitment to Chromatin. Molecular Cell, 70, 422-434 (2018) [pubmed]

【和文総説・書籍など】

 *1. 浜本　隆二：人工知能を用いた統合的ながん医療システムの開発と創薬研究への応用, In silico創薬におけるスクリーニングの高速化・高精度化技術（技術情報協会), 195-201 (2018)

*2. 小林　和馬, 浜本　隆二：人工知能技術によって変革される放射線医学, ファルマシア,　54, 875-878 (2018)

*3. 脇田　明尚, 小林　和馬, 浜本　隆二, 伊丹　純：深層学習の放射線治療への応用, Isotope News , 758, 12-15 (2018)

*4. 山田　真善, 浜本　隆二, 上條　憲一, 今岡　仁, 斎藤　豊：AIによる内視鏡画像からの病変部位の検知技術の開発. 最先端医療機器の病院への普及展望と今後の製品開発（技術情報協会)  (2018)